Interpharm Holdings Stock Market Value
| IPAH Stock | USD 0 0.00 0.00% |
| Symbol | Interpharm |
Interpharm Holdings Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Interpharm Holdings. If investors know Interpharm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Interpharm Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.09) | Revenue Per Share | Quarterly Revenue Growth (0.07) | Return On Assets | Return On Equity |
The market value of Interpharm Holdings is measured differently than its book value, which is the value of Interpharm that is recorded on the company's balance sheet. Investors also form their own opinion of Interpharm Holdings' value that differs from its market value or its book value, called intrinsic value, which is Interpharm Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Interpharm Holdings' market value can be influenced by many factors that don't directly affect Interpharm Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Interpharm Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Interpharm Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Interpharm Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Interpharm Holdings 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Interpharm Holdings' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Interpharm Holdings.
| 01/01/2025 |
| 12/27/2025 |
If you would invest 0.00 in Interpharm Holdings on January 1, 2025 and sell it all today you would earn a total of 0.00 from holding Interpharm Holdings or generate 0.0% return on investment in Interpharm Holdings over 360 days. Interpharm Holdings, Inc. develops, manufactures, and markets generic prescription strength and over-the-counter pharmac... More
Interpharm Holdings Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Interpharm Holdings' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Interpharm Holdings upside and downside potential and time the market with a certain degree of confidence.
Interpharm Holdings Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Interpharm Holdings' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Interpharm Holdings' standard deviation. In reality, there are many statistical measures that can use Interpharm Holdings historical prices to predict the future Interpharm Holdings' volatility.Interpharm Holdings Backtested Returns
We have found three technical indicators for Interpharm Holdings, which you can use to evaluate the volatility of the firm. The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Interpharm Holdings are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Interpharm Holdings has perfect predictability. Overlapping area represents the amount of predictability between Interpharm Holdings time series from 1st of January 2025 to 30th of June 2025 and 30th of June 2025 to 27th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Interpharm Holdings price movement. The serial correlation of 1.0 indicates that 100.0% of current Interpharm Holdings price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Interpharm Holdings lagged returns against current returns
Autocorrelation, which is Interpharm Holdings stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Interpharm Holdings' stock expected returns. We can calculate the autocorrelation of Interpharm Holdings returns to help us make a trade decision. For example, suppose you find that Interpharm Holdings has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Interpharm Holdings regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Interpharm Holdings stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Interpharm Holdings stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Interpharm Holdings stock over time.
Current vs Lagged Prices |
| Timeline |
Interpharm Holdings Lagged Returns
When evaluating Interpharm Holdings' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Interpharm Holdings stock have on its future price. Interpharm Holdings autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Interpharm Holdings autocorrelation shows the relationship between Interpharm Holdings stock current value and its past values and can show if there is a momentum factor associated with investing in Interpharm Holdings.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Interpharm Holdings Correlation, Interpharm Holdings Volatility and Interpharm Holdings Alpha and Beta module to complement your research on Interpharm Holdings. For more detail on how to invest in Interpharm Stock please use our How to Invest in Interpharm Holdings guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Interpharm Holdings technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.